Skip to main content
Independent and nonpartisan. SaveYourState is a civic information resource. It is not a government website and is not affiliated with any government agency, party, or campaign.

Colorado · 2026 Regular Session · Bill

HB 1262: Patient Access to Compounded Medical Items

Enacted Official data

  1. Introduced
  2. In committee
  3. Passed one chamber
  4. Passed both chambers
  5. Enacted

Last official action: ·Record last updated:

Plain-language summary

HB 1262 is a bill introduced in the Colorado House on February 19, 2026. According to its official title, it concerns: Patient Access to Compounded Medical Items. Primary sponsor: Dylan Roberts (Democratic), Matt Ball (Democratic), Rebekah Stewart (Democratic), Katie Stewart (Democratic). It lists 22 additional sponsors. Most recent recorded action (June 2, 2026): Governor Signed.

Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written

Official summary

Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.

The act provides that, if the action is undertaken in accordance with applicable federal and state law:A licensed person may compound a drug or device in the state;A state-licensed pharmacy or a distribution facility registered with the federal food and drug administration (licensed 503B outsourcing facility) may supply a compounded drug or device to a licensed health-care provider, pharmacy, facility, or organization; andA licensed health-care provider, pharmacy, facility, or organization may obtain, dispense, or administer a compounded drug or device supplied by a state-licensed pharmacy or a licensed 503B outsourcing facility.     In addition, the act prohibits the state board of pharmacy from adopting rules that are more restrictive than federal or state law regarding the compounding of drugs or devices by licensed 503B outsourcing facilities.     Current law exempts drugs that are intended solely for investigational use by experts qualified by scientific training and experience and that are plainly labeled for investigational use only from the sales and delivery prohibition for new drugs. The act also exempts from the prohibition:Drugs that are reviewed by an institutional review board and plainly labeled for investigational use only; andCompounded drugs and devices if the compounding of the drug or device is undertaken in accordance with applicable federal and state law.(Note: This summary applies to this bill as enacted.)

Sponsors

Sponsors by party (alphabetical): Democratic 24 · Republican 1

NameRolePartyChamberDistrict
Dylan RobertsPrimary sponsorDemocraticSenate8
Matt BallPrimary sponsorDemocraticSenate31
Rebekah StewartPrimary sponsorDemocraticHouse30
Katie StewartPrimary sponsorDemocraticHouse59
Jennifer BaconCo-sponsorDemocraticHouse7
Kyle BrownCo-sponsorDemocraticHouse12
Chad CliffordCo-sponsorDemocraticHouse37
Monica DuranCo-sponsorDemocraticHouse23
Cecelia EspenozaCo-sponsorDemocraticHouse4
Lorena GarcíaCo-sponsorDemocraticHouse35
Eliza HamrickCo-sponsorDemocraticHouse61
Jamie JacksonCo-sponsorDemocraticHouse41
Junie JosephCo-sponsorDemocraticHouse10
Sheila LiederCo-sponsorDemocraticHouse28
Mandy LindsayCo-sponsorDemocraticHouse42
Bob MarshallCo-sponsorDemocraticHouse43
Julie McCluskieCo-sponsorDemocraticHouse13
Karen McCormickCo-sponsorDemocraticHouse11
Kenny NguyenCo-sponsorDemocraticHouse33
Jacque PhillipsCo-sponsorDemocraticHouse31
Naquetta RicksCo-sponsorDemocraticHouse40
M. RutinelCo-sponsorNot applicable (committee)——
Emily SirotaCo-sponsorDemocraticHouse9
Lesley SmithCo-sponsorDemocraticHouse49
Brianna TitoneCo-sponsorDemocraticHouse27
Ron WeinbergCo-sponsorRepublicanHouse51

“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.

Recent official actions

  1. Governor Signed
  2. Signed by the Speaker of the House
  3. Signed by the President of the Senate
  4. Sent to the Governor
  5. House Considered Senate Amendments - Result was to Concur - Repass
  6. House Considered Senate Amendments - Result was to Laid Over Daily
  7. Senate Third Reading Passed - No Amendments
  8. Senate Second Reading Passed with Amendments - Committee
  9. Senate Second Reading Laid Over to 04/16/2026 - No Amendments
  10. Senate Committee on Health & Human Services Refer Amended - Consent Calendar to Senate Committee of the Whole
  11. Introduced In Senate - Assigned to Health & Human Services
  12. House Third Reading Passed - No Amendments

Showing 12 most recent of 15 actions. Full history

Sources

  1. Open States / Plural (data from the official legislature website)
  2. Official legislature source